📖完整指南✅2026 更新🔬循证医学
Icosema 指南
Novo Nordisk
Icosema 完整指南。Icosema 是 Novo Nordisk 开发的创新药物。
Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Medication Supply
Icosema
~42 days left · Mar 15
B12
~88 days left · May 8
Retatrutide
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
IcosemaRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Medication Supply
Icosema
~42 days left · Mar 15
B12
~88 days left · May 8
Retatrutide
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
IcosemaRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
01BACKGROUND
Novo Nordisk 的 Insulin Icodec + Semaglutide 固定比例复方制剂
Icosema 是 Novo Nordisk 正在研发的一种固定比例复方制剂，由 Insulin Icodec（每周一次的基础胰岛素）和 Semaglutide（GLP-1 受体激动剂）组成。通过将两者结合在每周一次的单次注射中，它旨在简化糖尿病管理，同时提供 GLP-1 疗法的代谢益处和胰岛素的强效降糖作用。使用 Shotlee 应用记录您当前的方案，并为未来的治疗积累基准数据。
02DEEP DIVE
什么是 Icosema？
Icosema 是 Novo Nordisk 正在研发的一种固定比例复方制剂，由 Insulin Icodec（每周一次的基础胰岛素）和 Semaglutide（GLP-1 受体激动剂）组成。通过将两者结合在每周一次的单次注射中，它旨在简化糖尿病管理，同时提供 GLP-1 疗法的代谢益处和胰岛素的强效降糖作用。
在科学不断进步的同时，请在 Shotlee 中记录您当前的方案。拥有清晰的历史数据意味着如果您将来更换药物，可以精确地对比疗效。
03WHAT TO TRACK
工作原理
01
🔬
Insulin Icodec
Once-weekly basal insulin. Steady glucose control. Reduces injection burden. Track insulin data in Shotlee
02
🔬
Semaglutide Component
GLP-1 receptor agonist. Appetite suppression. Weight management benefits. Log weight trends in Shotlee
03
✅
Combination Advantage
Single weekly injection. Simplified regimen. Dual metabolic action. Monitor both effects in Shotlee
04
🔬
Why This Matters
Managing both insulin and GLP-1 therapy in a single weekly injection dramatically simplifies treatment for people with Type 2 diabetes. Tracking dose adherence and metabolic markers in Shotlee ensures
04DEEP DIVE
临床数据
多项 3 期临床试验（COMBINE 项目）正在评估 Icosema 在 2 型糖尿病人群中的表现。
05MECHANICS
副作用
1
低血糖（胰岛素成分引起）
2
胃肠道症状（Semaglutide 成分引起）
3
注射部位反应
4
在 Shotlee 中记录所有副作用
06WHAT TO TRACK
关键方案常见问题
01
🔬
What is Icosema?
Icosema is a fixed-ratio combination of once-weekly insulin icodec and semaglutide in a single injection. It is designed for people with Type 2 diabetes. Track your insulin and GLP-1 protocols togethe
02
🔬
Is Icosema approved?
Icosema is still in Phase 3 trials. Use Shotlee to track your current insulin and GLP-1 protocols while awaiting results.
07FAQ
指南常见问题
Icosema 完整指南。Icosema 是 Novo Nordisk 开发的创新药物。
可以。Shotlee 支持记录 Icosema 剂量、副作用和健康指标。该应用可免费使用。
Free · Always
在 Shotlee 中记录您的 Icosema 方案
免费的剂量日志、副作用跟踪和健康指标监测，为您提供完整的方案管理。
📚References & sources
1